Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Last updated: January 9, 2019
Sponsor: Allergan
Overall Status: Completed

Phase

4

Condition

Hair Loss

Alopecia

Treatment

N/A

Clinical Study ID

NCT01229423
LAT-KOR-01
  • Ages > 18
  • Female

Study Summary

This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Eyelash prominence assessment of minimal or moderate

  • Of Korean ethnicity

Exclusion

Exclusion Criteria:

  • Any eye disease or abnormality

  • Any ocular surgery or use of any eyelash extension or eyelash growth products within 3months

  • Any permanent eyeliner within 5 years

  • Eyelash implants of any kind

  • Eyelash tint or dye application within 2 months

  • Use of any treatment that may affect hair growth within 6 months

Study Design

Total Participants: 62
Study Start date:
November 01, 2009
Estimated Completion Date:
October 31, 2010

Connect with a study center

  • Seoul,
    Korea, Republic of

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.